These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23260019)

  • 1. HIV-1 associated Topoisomerase IIβ kinase: a potential pharmacological target for viral replication.
    Ponraj K; Prabhakar M; Rathore RS; Bommakanti A; Kondapi AK
    Curr Pharm Des; 2013; 19(26):4776-86. PubMed ID: 23260019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of pyridine dicoumarols as potent anti HIV-1 leads, targeting HIV-1 associated topoisomeraseIIβ kinase.
    Kammari K; Devaraya K; Bommakanti A; Kondapi AK
    Future Med Chem; 2017 Sep; 9(14):1597-1609. PubMed ID: 28891315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes.
    Kondapi AK; Satyanarayana N; Saikrishna AD
    Arch Biochem Biophys; 2006 Jun; 450(2):123-32. PubMed ID: 16712776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of topoisomerase II alpha and beta in HIV-1 infected and uninfected neuroblastoma and astrocytoma cells: involvement of distinct nordihydroguaretic acid sensitive inflammatory pathways.
    Mandraju RK; Kondapi AK
    Arch Biochem Biophys; 2007 May; 461(1):40-9. PubMed ID: 17391642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription.
    Lokeswara Balakrishna S; Satyanarayana N; Kondapi AK
    Arch Biochem Biophys; 2013 Apr; 532(2):91-102. PubMed ID: 23399433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication.
    Sunnam LBK; Kondapi AK
    Mol Biotechnol; 2021 Aug; 63(8):732-745. PubMed ID: 33993458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest.
    Chikamori K; Hill JE; Grabowski DR; Zarkhin E; Grozav AG; Vaziri SA; Wang J; Gudkov AV; Rybicki LR; Bukowski RM; Yen A; Tanimoto M; Ganapathi MK; Ganapathi R
    Leukemia; 2006 Oct; 20(10):1809-18. PubMed ID: 16932348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus.
    Kondapi AK; Padmaja G; Satyanarayana N; Mukhopadyaya R; Reitz MS
    Arch Biochem Biophys; 2005 Sep; 441(1):41-55. PubMed ID: 16091284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of topoisomerase II catalytic inhibitors against Epstein-Barr virus.
    Wu T; Wang Y; Yuan Y
    Antiviral Res; 2014 Jul; 107():95-101. PubMed ID: 24821256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of African swine fever virus-topoisomerase II disrupts viral replication.
    Freitas FB; Frouco G; Martins C; Leitão A; Ferreira F
    Antiviral Res; 2016 Oct; 134():34-41. PubMed ID: 27568922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIbeta: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability.
    West KL; Turnbull RM; Willmore E; Lakey JH; Austin CA
    Nucleic Acids Res; 2002 Dec; 30(24):5416-24. PubMed ID: 12490710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.
    Takahashi H; Matsuda M; Kojima A; Sata T; Andoh T; Kurata T; Nagashima K; Hall WW
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5694-8. PubMed ID: 7539924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
    Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
    Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The topoisomerase II β -kinase associated with HIV-1 is a potential target for pyridine-bischalcones' anti-HIV-1 activity.
    Kammari K; Devaraya K; Swain S; Kondapi AK
    Eur J Med Chem; 2023 Nov; 259():115623. PubMed ID: 37473689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CoMFA and CoMSIA studies on HIV-1 attachment inhibitors.
    Lu P; Wei X; Zhang R
    Eur J Med Chem; 2010 May; 45(5):1792-8. PubMed ID: 20149491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs.
    Chen W; Qiu J; Shen YM
    Drug Discov Ther; 2012 Oct; 6(5):230-7. PubMed ID: 23229142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling of cationic porphyrin-anthraquinone hybrids as DNA topoisomerase IIβ inhibitors.
    Arba M; Ruslin ; Ihsan S; Tri Wahyudi S; Tjahjono DH
    Comput Biol Chem; 2017 Dec; 71():129-135. PubMed ID: 29153891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of DNA Topoisomerase IIbeta through RNA-dependent association with heterogeneous nuclear ribonucleoprotein U (hnRNP U).
    Kawano S; Miyaji M; Ichiyasu S; Tsutsui KM; Tsutsui K
    J Biol Chem; 2010 Aug; 285(34):26451-60. PubMed ID: 20554522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of dihydroxylated 2,4-diphenyl-6-thiophen-2-yl-pyridine as a non-intercalative DNA-binding topoisomerase II-specific catalytic inhibitor.
    Jun KY; Kwon H; Park SE; Lee E; Karki R; Thapa P; Lee JH; Lee ES; Kwon Y
    Eur J Med Chem; 2014 Jun; 80():428-38. PubMed ID: 24796883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine transgenic cells lacking DNA topoisomerase IIbeta are resistant to acridines and mitoxantrone: analysis of cytotoxicity and cleavable complex formation.
    Errington F; Willmore E; Tilby MJ; Li L; Li G; Li W; Baguley BC; Austin CA
    Mol Pharmacol; 1999 Dec; 56(6):1309-16. PubMed ID: 10570059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.